Analysis of Patient Cost for Recombinant Human Platelet-Derived Growth Factor Therapy as the First-line Treatment of the Insured Patient with a Diabetic Foot Ulcer
Analysis of Patient Cost for Recombinant Human Platelet-Derived Growth Factor Therapy as the First-line Treatment of the Insured Patient with a Diabetic Foot Ulcer
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started